(Q33938828)

30 July 2017

1 reference

title

The prevention of Lyme disease with vaccine (English)

1 reference

ORCID Public Data File 2021

30 July 2017

0 references

1 reference

author name string

Poland GA

series ordinal

1

1 reference

30 July 2017

Jacobson RM

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

30 July 2017

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

17-19

1 reference

30 July 2017

page(s)

2303-2308

1 reference

Erythema Chronicum Migrans

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

1 reference

7 January 2021

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

A cost-of-illness study of Lyme disease in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Lyme disease prevention and vaccine prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Suppression of Ixodes scapularis (Acari: Ixodidae) nymphs in a large residential community.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Reduction of nymphal Ixodes dammini (Acari: Ixodidae) in a residential suburban landscape by area application of insecticides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Environmental risk and prevention of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Reduction of Lyme disease exposure by recognition and avoidance of high-risk areas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Occupational risk of Lyme disease in endemic areas of New York State

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Case-control study of risk factors for incident Lyme disease in California.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Emergence of Lyme disease in Hunterdon County, New Jersey, 1993: a case-control study of risk factors and evaluation of reporting patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Assessing the prevention effectiveness of local Lyme disease control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Prevalence of Ixodes dammini near the homes of Lyme disease patients in Westchester County, New York

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Treatment of clothing with a permethrin spray for personal protection against the western black-legged tick, Ixodes pacificus (Acari: Ixodidae).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Mosquitoes and mosquito repellents: a clinician's guide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Active immunization of hamsters against experimental infection with Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Passive immunization of hamsters against experimental infection with the Lyme disease spirochete

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Prospects for a vaccine to prevent Lyme disease in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Protection of mice against the Lyme disease agent by immunizing with recombinant OspA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

1 reference

7 January 2021

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Efficacy of human Lyme disease vaccine formulations in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Western blotting in the serodiagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: antibody persistence and effect of a booster dose at month 12

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Pediatric immunization for the future. Lyme disease vaccine and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Possible cause found for Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Lyme arthritis: lessons learned and to be learned

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Management of Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

The cost effectiveness of vaccinating against Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Underreporting of Lyme disease by Connecticut physicians, 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

Underreporting of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

The public health impact of Lyme disease in Maryland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900520-X

7 January 2021

10.1016/S0264-410X(00)00520-X

Identifiers

DOI

1 reference

30 July 2017

1 reference